Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 194-198, January 1, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morgan, A. R.
Right arrow Articles by Selman, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morgan, A. R.
Right arrow Articles by Selman, S. H.

New Photosensitizers for Photodynamic Therapy: Combined Effect of Metallopurpurin Derivatives and Light on Transplantable Bladder Tumors1

Alan R. Morgan2, Greta M. Garbo, Rick W. Keck and Steven H. Selman

Department of Chemistry, University of Toledo, and Department of Surgery/Urology, Medical College of Ohio, Toledo, Ohio 43606

A series of metallopurpurins was tested for their photodynamic activity against transplantable N-[4-(5-nitro-2-furyl)-2-thiazoyl]formamide-induced urothelial tumors growing in male Fischer CDF (F344/CrlBR) rats. Histological examination of tumors in animals treated with the metallopurpurins and red light (>590 nm, 360 J/cm2) revealed tumor necrosis 24 h after completion of therapy. Control tumors showed no histological change.

In 30-day tumor regrowth studies, 70% of animals treated with the metallopurpurin derivative SnET2 were free of tumors while 50% of the animals treated with the free-base purpurin ET2 were free of tumor.

Metallopurpurins have intense absorptions in the red region of the visible spectrum, a region with good tissue penetration. The metallopurpurins are easily prepared from the corresponding purpurins with a high degree of purity. This study demonstrates the potential of these photosensitizers for photodynamic cancer therapy.

1 Supported in part by PHS Grants R01 CA43006 and R23 CA38754 awarded by the National Cancer Institute, Department of Health and Human Services.

2 To whom all correspondence should be addressed, at Department of Chemistry, University of Toledo, 2801 W. Bancroft Street, Toledo, OH 43606.

Received 1/20/87. Revised 7/30/87. Accepted 10/ 7/87.




This article has been cited by other articles:


Home page
Cancer Res.Home page
D. Kessel, J. A. Caruso, and J. J. Reiners Jr.
Potentiation of Photodynamic Therapy by Ursodeoxycholic Acid
Cancer Res., December 1, 2000; 60(24): 6985 - 6988.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.